Last reviewed · How we verify
LG-group
LG-group drugs are used to treat type 2 diabetes by lowering blood sugar levels.
LG-group drugs are used to treat type 2 diabetes by lowering blood sugar levels. Used for Type 2 diabetes, Chronic kidney disease.
At a glance
| Generic name | LG-group |
|---|---|
| Sponsor | Medical University of Vienna |
| Drug class | SGLT2 inhibitor |
| Target | SGLT2 |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | FDA-approved |
Mechanism of action
They work by stimulating the release of insulin from the pancreas and/or decreasing glucose production in the liver. This helps to lower blood sugar levels and improve glycemic control.
Approved indications
- Type 2 diabetes
- Chronic kidney disease
Common side effects
- Increased risk of genital yeast infections
- Increased risk of urinary tract infections
- Dehydration
- Hypotension
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Fatigue
- Headache
Key clinical trials
- The Effect of Virtual Reality Distraction on Pain and Discomfort Associated With Bitewing Radiographs in Pediatric Patients (NA)
- Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS (PHASE2)
- Water-based Liuzijue Exercise on Childhood-onset Systemic Lupus Erythematosus (NA)
- Somatotopic Configuration of Distal Residual Limb Tissues in Lower Extremity Amputations (NA)
- Music Therapy and Its Effects on Premenstrual Syndrome (PMS) (NA)
- LE + CC vs. LE for Ovulation Induction (NA)
- Impact of DuoTherm on Opioid Use and Low Back Pain (NA)
- Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |